{"version":"1.0","type":"link","title":"Randomized pilot study of camrelizumab with or without autologous cytokine-induced killer cells in refractory clear cell renal cell carcinoma.","author_name":"Li S 외","author_url":"https://prs-insight.online/author/Li%20S","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/168413","thumbnail_width":1200,"thumbnail_height":630}